Salim Syed
Managing Director, Senior Biotechnology Analyst, Equity Research

Years in the industry: 10 years
Area of focus: Biotechnology equity research 
School: University of Michigan

 

What do you do at Mizuho?
It's pretty simple -- I'm here to help clients. I mainly do this by analyzing biotech stocks to aid them with their investment processes. Investors have tough jobs, probably a lot harder than mine. So my goal is to help them achieve their goal.

What surprised you about Mizuho?
The sheer drive of so many folks throughout the firm to expand our US equities business. This sort of character and action is powerful to witness first-hand.

What’s the first thing you read every day?
Email. There’s always a lot of news that comes out overnight and early in the morning in my space. As an analyst, it's my job to review, digest and comment on what is relevant to investors. Usually mixed in with the news are client emails. Clients are the center of my business, so I make sure to get back to every single email as quickly as I can.

How have you grown since joining Mizuho?
Being an entrepreneur. Mizuho is a large, established firm. However, the US equities business is relatively new. This presents opportunities to influence its direction, build, take calculated risks and do things a little bit differently than other places. I truly appreciate that and hope to be a better analyst because of it.

What do you do for fun?
I'm fortunate that I get to work and live in New York City, one of the greatest cities in the world. Although I would like to say that I swim the Hudson regardless of the season, I generally keep things simple. This means spending time with family and friends, working out, and enjoying the city every second that life affords me.